Regulations.gov document
Intramammary Dosage Forms; Cephapirin Benzathine
Rule · FDA-2008-N-0039 · posted Mar 7, 2008
Key facts
| Document ID | FDA-2008-N-0039-0015 |
|---|---|
| Title | Intramammary Dosage Forms; Cephapirin Benzathine |
| Document type | Rule |
| Subtype | Final Rule |
| Agency | FDA |
| Docket | FDA-2008-N-0039 |
| Posted | Mar 7, 2008 |
| FR document number | E8-04473 |
| CFR | 21 CFR 526 |
| Comment period opens | Mar 7, 2008 |
| Effective date | Mar 7, 2008 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: